Selzentry 300 MG Oral Tablet

RxCUI: 729203
RxNorm name: Selzentry 300 MG Oral Tablet
Display name: Selzentry 300 MG Oral Tablet
Full name: Selzentry 300 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SELZENTRY	MARAVIROC	ViiV Healthcare Company	46f30ac5-c96b-429e-976d-8c5ee1c0761b	2022-09-26	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 729203

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
46f30ac5-c96b-429e-976d-8c5ee1c0761b	Selzentry 300 MG Oral Tablet	PSN	25	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007	20220926
46f30ac5-c96b-429e-976d-8c5ee1c0761b	maraviroc 300 MG Oral Tablet [Selzentry]	SBD	25	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007	20220926
46f30ac5-c96b-429e-976d-8c5ee1c0761b	Selzentry 300 MG Oral Tablet	SY	25	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007	20220926
2b5e5c5d-852a-413b-825c-8491d4539e67	maraviroc 300 MG Oral Tablet [Selzentry]	SBD	1	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) Tablets Initial U.S. Approval: 2007	20120523
2b5e5c5d-852a-413b-825c-8491d4539e67	Selzentry 300 MG Oral Tablet	PSN	1	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) Tablets Initial U.S. Approval: 2007	20120523
2b5e5c5d-852a-413b-825c-8491d4539e67	Selzentry 300 MG Oral Tablet	SY	1	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) Tablets Initial U.S. Approval: 2007	20120523